Cited by 104Metabolomics and Mass Spectrometry StudiesDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride

Huo, Taoguang, Cai, Shuang, Lu, Xiumei, Sha, Yi, Yu, Mingyang, Li, Famei·2009·Journal of Pharmaceutical and Biomedical Analysis

Abstract

A metabonomic study on biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride was performed. (1)H NMR and UPLC/MS were used to generate metabolic fingerprints for the metabonomic analysis of serum samples obtained from 20 type 2 diabetes mellitus patients without any drugs treatment and 15 type 2 diabetes mellitus patients treated with metformin hydrochloride for 3 months. The resulting data were subjected to chemometric analysis (principal component analysis and partial least squares discriminant analysis) to investigate the effect of metformin hydrochloride on serum metabolite profiles of type 2 diabetes mellitus patients. (1)H NMR spectroscopic analysis revealed increased trimethylamine-N-oxide (TMAO), 3-hydroxybutyrate (3-HB) and decreased glucose, N-acetyl glycoprotein (NAC), lipoprotein, lactate, acetoacetate and unsaturated lipids in serum from metformin treated patients compared to untreated ones. UPLC/MS in positive electrospray ionization detected increased tryptophan and decreased lysophosphatidylcholines (C16:0 LPC, C18:0 LPC and C18:2 LPC) as well as phenylalanine in treated group. Both analytical techniques used in this study were able to detect biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride, which may be helpful to the understanding of action mechanism of metformin hydrochloride.

Integrity signals

Registry

Crossref · 10.1016/j.jpba.2009.01.008

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Diabetic patients treated with metformin had decreased glucose but increased plasma TMAO compared with untreated individuals.

    “By contrast, patients with diabetes treated with metformin had decreased glucose but increased plasma TMAO concentrations compared with untreated individuals (55).”

The citation lists haven’t been fetched yet

References 49 · Cited by 104

Authors
Huo, T., Cai, S., Lu, X., Sha, Y., Yu, M., & Li, F.
Affiliations
Shenyang Pharmaceutical University (CN)
Corresponding author
Li, Famei
Venue
Journal of Pharmaceutical and Biomedical Analysis
Publisher
Elsevier BV
Published
2009-05
Volume
49
Issue
4
Pages
976-982
ISSN
0731-7085 (ISSN-L)
OpenAlex
W1963857188
Cited by
104
References
49
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 9 · 2015: 7 · 2014: 11 · 2013: 11 · 2012: 8
FWCI
3.62
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pharmaceutical and Biomedical Analysis (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Education of the People's Republic of China (20060163004)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, metformin hydrochloride, serum metabolites, metabolomics, trimethylamine N-oxide, beta-hydroxybutyrate, tryptophan, lysophosphatidylcholine, phenylalanine, mechanism of action, metabolic fingerprint
MeSH terms
Chromatography, High Pressure Liquid, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Metformin, Magnetic Resonance Spectroscopy, Reference Standards, Mass Spectrometry, Reproducibility of Results, Biomarkers, Multivariate Analysis, Least-Squares Analysis, Spectrometry, Mass, Electrospray Ionization, Principal Component Analysis, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review